There is a huge range in readiness when it comes to making the move to merit-based incentive payments, but in order to successful make the transition successfully, organizations need the structures in place, the leadership on board, and relationships with the community, explained Elizabeth Mitchell, president and CEO of the Network for Regional Healthcare Improvement.
There is a huge range in readiness when it comes to making the move to merit-based incentive payments, but in order to successful make the transition successfully, organizations need the structures in place, the leadership on board, and relationships with the community, explained Elizabeth Mitchell, president and CEO of the Network for Regional Healthcare Improvement.
Transcript (slightly modified)
How ready are physicians and healthcare organizations for the move to merit-based incentive payments?
I think there is a real range in readiness among physicians to accept and manage risk. It’s a huge change—it requires new data systems, new practice patterns, new team relationships, new community relationships. And there are some providers who have been moving in that direction for quite some time and some who really just haven’t.
I think there is an inevitability of change and that seems to be at least really penetrating the thinking. But a lot of people don’t even know where to start or how to start. So I think there is going to be a lot of activity—really creating the building blocks to actually be ready to manage risk.
And hopefully we will learn from those who went first and really benefit the ones still going in that direction.
How can those who haven’t started yet prepare for the change?
I actually was meeting with the chief medical officer of a major health system just yesterday and he said that he called all of his physicians in to a room, across the whole system, and said, “We’re going to be changing everything. And you’re going to need analytics, new EHRs, new ways of data sharing, new ways of leading, and if you’re not ready, you probably should work somewhere else.”
So it is, I think, coming from the leaders now that this has to happen. I think that is the first step: showing that leadership and saying, “we’re going to do this.”
But, again, you need the structures in place. If you don’t have data, you can’t manage a population. If you don’t have relationships with community providers or public health or the much broader world outside the hospital walls, you’re not going to be successful in population health models.
So you can start now: leadership and then structures and then new relationships are really what have to come first.
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More